Syndax Pharmaceuticals (SNDX) Gross Profit: 2015-2024
Historic Gross Profit for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Dec 2024 value amounting to $22.9 million.
- Syndax Pharmaceuticals' Gross Profit changed negligibly% to $380,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $22.9 million for FY2024, which is 11087.50% up from last year.
- Syndax Pharmaceuticals' Gross Profit amounted to $22.9 million in FY2024, which was up 11,087.50% from -$208,000 recorded in FY2023.
- Syndax Pharmaceuticals' 5-year Gross Profit high stood at $139.7 million for FY2021, and its period low was -$3.1 million during FY2022.
- For the 3-year period, Syndax Pharmaceuticals' Gross Profit averaged around $6.5 million, with its median value being -$208,000 (2023).
- In the last 5 years, Syndax Pharmaceuticals' Gross Profit tumbled by 102.25% in 2022 and then surged by 11,087.50% in 2024.
- Over the past 5 years, Syndax Pharmaceuticals' Gross Profit (Yearly) stood at $1.5 million in 2020, then spiked by 9,109.56% to $139.7 million in 2021, then tumbled by 102.25% to -$3.1 million in 2022, then soared by 93.37% to -$208,000 in 2023, then surged by 11,087.50% to $22.9 million in 2024.